ghk-cu copper peptide hair growth clinical study GHK Trial (2016) — Research Summary GHK-Cu Hair Growth Guide: Protocols

Monitor with bloodwork every 3-6 months

Studies indicate activation of VEGFR2 and downstream Akt-eNOS pathways, supporting nitric oxide production and angiogenesis in both cellular and animal models

Contrary to our hypotheses, we observed no significant group differences in either GSH or GABA+ concentrations in any of the four brain regions of interest: SM1, Thal, mPFC, and SMA

FDA regulators said at the time that the substances "present significant safety risks" because of the lack of testing

At the end of visit 4, children were randomized to either placebo (rice protein) or intervention (CRWP) and parents were given a diary to measure adverse effects or unusual events, together with the canister containing the study product in powder form with a measuring scoop